Microbot Medical Inc. (MBOT)
NasdaqCM · USD · Healthcare · Medical Devices
$0.9915 (+5.26%) as of
Key statistics
- Market cap
- 66.59M
- Forward P/E
- -3.10
- EPS (TTM)
- -0.2500
- Dividend yield
- 0.00%
- 52-week range
- 0.9300 – 2.8600
- Beta
- 1.05
- Revenue (TTM)
- 346k
- Profit margin
- 0.00%
- Analyst target
- $5.38
- Volume
- 410.74k
About Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hingham, MA, United States
- Employees
- 43
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.